Results 61 to 70 of about 1,487,216 (331)

Towards a Unified Knowledge-Based Approach to Modality Choice [PDF]

open access: yes, 2007
This paper advances a unified knowledge-based approach to the process of choosing the most appropriate modality or combination of modalities in multimodal output generation.
Bachvarova, Yulia   +2 more
core   +1 more source

Adversarial Inpainting of Medical Image Modalities

open access: yes, 2018
Numerous factors could lead to partial deteriorations of medical images. For example, metallic implants will lead to localized perturbations in MRI scans.
Armanious, Karim   +3 more
core   +1 more source

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

open access: yesMolecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu   +12 more
wiley   +1 more source

Multimodal Continuous Turn-Taking Prediction Using Multiscale RNNs

open access: yes, 2018
In human conversational interactions, turn-taking exchanges can be coordinated using cues from multiple modalities. To design spoken dialog systems that can conduct fluid interactions it is desirable to incorporate cues from separate modalities into turn-
Harte, Naomi   +2 more
core   +1 more source

Imaging modalities in synchronous oligometastatic prostate cancer [PDF]

open access: yes, 2019
Purpose Along with a number of other malignancies, the term "oligometastatic" prostate cancer has recently emerged. It represents an attempt to define a subtype of cancer with a limited metastatic load that might perform more favorably than a distinctly ...
Bergh, R. van den   +14 more
core   +2 more sources

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

Synthesis, Characterization, and in vivo Evaluation of a Novel Potent Autotaxin-Inhibitor

open access: yesFrontiers in Pharmacology, 2022
The autotaxin-lysophosphatidic acid (ATX-LPA) signaling pathway plays a role in a variety of autoimmune diseases, such as rheumatoid arthritis or neurodegeneration.
Daniel Hunziker   +19 more
doaj   +1 more source

HeMIS: Hetero-Modal Image Segmentation

open access: yes, 2016
We introduce a deep learning image segmentation framework that is extremely robust to missing imaging modalities. Instead of attempting to impute or synthesize missing data, the proposed approach learns, for each modality, an embedding of the input image
B Menze   +10 more
core   +1 more source

Exploiting Multiple Sensory Modalities in Brain-Machine Interfaces [PDF]

open access: yes, 2009
Recent improvements in cortically-controlled brain-machine interfaces (BMIs) have raised hopes that such technologies may improve the quality of life of severely motor-disabled patients.
Hatsopoulos, Nicholas G.   +2 more
core   +2 more sources

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

open access: yesMolecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy